Biologics in steroid resistant nephrotic syndrome in childhood: review and new hypothesis-driven treatment

Nephrotic syndrome affects about 2–7 per 100,000 children yearly and accounts for less than 15% of end stage kidney disease. Steroids still represent the cornerstone of therapy achieving remission in 75–90% of the cases The remaining part result as steroid resistant nephrotic syndrome, characterized...

Descripción completa

Detalles Bibliográficos
Autores principales: Angeletti, Andrea, Bruschi, Maurizio, Kajana, Xhuliana, La Porta, Edoardo, Spinelli, Sonia, Caridi, Gianluca, Lugani, Francesca, Verrina, Enrico Eugenio, Ghiggeri, Gian Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497215/
https://www.ncbi.nlm.nih.gov/pubmed/37705972
http://dx.doi.org/10.3389/fimmu.2023.1213203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497215/
https://www.ncbi.nlm.nih.gov/pubmed/37705972
http://dx.doi.org/10.3389/fimmu.2023.1213203

Ejemplares similares